Metastatic Lung Cancer Global Clinical Trials Review, H1, 2012

GlobalData, January 2012, Pages: 73

Metastatic Lung Cancer Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “Metastatic Lung Cancer Global Clinical Trials Review, H1, 2012" provides data on the Metastatic Lung Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Lung Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Lung Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Metastatic Lung Cancer Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Metastatic Lung Cancer , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

List of Tables
List of Figures
Introduction
Metastatic Lung Cancer
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Metastatic Lung Cancer
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Metastatic Lung Cancer Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Novartis AG
Clinical Trial Overview of Novartis AG
Clinical Trial Overview of Top Universities / Institutes / Hospitals
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Barbara Ann Karmanos Cancer Institute
Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute
H. Lee Moffitt Cancer Center & Research Institute
Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute
University of California, San Diego
Clinical Trial Overview of University of California, San Diego
Radboud University
Clinical Trial Overview of Radboud University
The Cancer Biotherapy Research Group
Clinical Trial Overview of The Cancer Biotherapy Research Group
Oita University
Clinical Trial Overview of Oita University
Tokyo Women's Medical University
Clinical Trial Overview of Tokyo Women's Medical University
Shizuoka Cancer Center
Clinical Trial Overview of Shizuoka Cancer Center
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
Institut Gustave Roussy
Clinical Trial Overview of Institut Gustave Roussy
Erasmus MC
Clinical Trial Overview of Erasmus MC
Cleveland Clinic Hospital
Clinical Trial Overview of Cleveland Clinic Hospital
University College London
Clinical Trial Overview of University College London
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Research Center
Clinical Trial Overview of Fred Hutchinson Cancer Research Center
Virginia Commonwealth University
Clinical Trial Overview of Virginia Commonwealth University
Wake Forest University
Clinical Trial Overview of Wake Forest University
The University of Tokyo
Clinical Trial Overview of The University of Tokyo
The First Affiliated Hospital of Guangzhou Medical College
Clinical Trial Overview of The First Affiliated Hospital of Guangzhou Medical College
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

List of Tables
Metastatic Lung Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012-
Metastatic Lung Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Metastatic Lung Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials, Europe, Top Countries, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials, BRIC Countries, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials, G7 Countries, 2012-
Metastatic Lung Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials, E7 Countries, 2012-
Metastatic Lung Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Metastatic Lung Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012-
Metastatic Lung Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012-
Metastatic Lung Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Metastatic Lung Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Metastatic Lung Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cancer Biotherapy Research Group, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Oita University, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Tokyo Women's Medical University, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Shizuoka Cancer Center, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut Gustave Roussy, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Cleveland Clinic Hospital, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University College London, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Virginia Commonwealth University, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The First Affiliated Hospital of Guangzhou Medical College, 2012-

List of Figures
Metastatic Lung Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012-
Metastatic Lung Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Metastatic Lung Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials, Europe, Top Countries (%), 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012-
Metastatic Lung Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Metastatic Lung Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Metastatic Lung Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012-
Metastatic Lung Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012-
Metastatic Lung Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Metastatic Lung Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Metastatic Lung Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
GlobalData Methodology

Customers who bought this item also bought

• Acute Lung Injury Global Clinical Trials Review, H2, 2012
• Global Oncology Drug Pipeline Capsule – 2012
• Cancer Cachexia Global Clinical Trials Review, H1, 2013
• Lung Injury Global Clinical Trials Review, H1, 2012
• Other Metabolic Disorders Global Clinical Trials Review, H1, 2012
• Myelofibrosis Global Clinical Trials Review, H2, 2012
• Osteoporosis Global Clinical Trials Review, H2, 2012
• Shock Global Clinical Trials Review, H2, 2012
• Cachexia Global Clinical Trials Review, H1, 2013
• Atopic Dermatitis (Eczema) Global Clinical Trials Review, H1, 2012